ACOR – acorda therapeutics, inc. (US:NASDAQ)

News

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Acorda Therapeutics Announces Nasdaq Delisting Notification [Yahoo! Finance]
Acorda Therapeutics Announces Nasdaq Delisting Notification
CALM,PLAY and VNDA are among after hour movers [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com